Cite
Medullary Pancreatic Carcinoma Due to Somatic POLE Mutation: A Distinctive Pancreatic Carcinoma With Marked Long-Term Survival.
MLA
Kryklyva, Valentyna, et al. “Medullary Pancreatic Carcinoma Due to Somatic POLE Mutation: A Distinctive Pancreatic Carcinoma With Marked Long-Term Survival.” Pancreas, vol. 49, no. 7, Aug. 2020, pp. 999–1003. EBSCOhost, https://doi.org/10.1097/MPA.0000000000001588.
APA
Kryklyva, V., Ter Linden, E., Kroeze, L. I., de Voer, R. M., van der Kolk, B. M., Stommel, M. W. J., Hermans, J. J., Luchini, C., Wood, L. D., Hruban, R. H., Nagtegaal, I. D., Ligtenberg, M. J. L., & Brosens, L. A. A. (2020). Medullary Pancreatic Carcinoma Due to Somatic POLE Mutation: A Distinctive Pancreatic Carcinoma With Marked Long-Term Survival. Pancreas, 49(7), 999–1003. https://doi.org/10.1097/MPA.0000000000001588
Chicago
Kryklyva, Valentyna, Esther Ter Linden, Leonie I Kroeze, Richarda M de Voer, B Marion van der Kolk, Martijn W J Stommel, John J Hermans, et al. 2020. “Medullary Pancreatic Carcinoma Due to Somatic POLE Mutation: A Distinctive Pancreatic Carcinoma With Marked Long-Term Survival.” Pancreas 49 (7): 999–1003. doi:10.1097/MPA.0000000000001588.